Identification and function of type IV IFN, IFN-υ and its receptor subunits, IFN-υR1 and IL-10RB in chicken Gallus gallus Authors: Shan Zhang, Tian Shun Wei, Chao Wei Zhang, Xiao Yuan Xu, Jing Wei Song, Peng Fei Mu, Bang Xiao, Su Wang, Bo Li, Pin Nie Published: 2026 ABSTRACT AbstractInterferons (IFNs) are central cytokines orchestrating antiviral innate immunity across vertebrates. Type IV IFN represents a recently identified and evolutionarily conserved IFN family. But, its molecular characteristics and biological functions in poultry species remain incompletely understood. In this study, we systematically identified and characterized chicken (Gallus gallus) type IV IFN, IFN-υ, together with its receptor subunits IFN-υR1 and IL-10RB, and investigated their evolutionary features, expression pattern, receptor distribution, and antiviral activity. Synteny and phylogenetic analyses demonstrated that chicken IFN-υ is embedded within a highly conserved genomic locus and clusters distinctly within the type IV IFN lineage, clearly separated from type I, II, and III IFNs, while sequence analysis revealed conserved structural hallmarks, including an N-terminal signal peptide, a conserved sequence CXXXXX[W/L], an invariant C-terminal CAWE motif and a predicted multi-helix structure. Quantitative expression analyses showed that IFN-υ is constitutively expressed in multiple chicken tissues, with relatively higher basal levels in immune-related and mucosal organs, and is differentially induced by poly(I:C) stimulation in a tissue- and time-dependent manner, whereas both receptor subunits were ubiquitously expressed and dynamically regulated following poly(I:C) challenge. Recombinant chicken IFN-υ was successfully expressed and purified as a monomeric protein and effectively induced representative IFN-stimulated genes (ISGs), confirming its biological activity. Importantly, IFN-υ significantly suppressed Tembusu virus (TMUV) replication by inhibiting viral gene expression and markedly attenuated virus-induced cytopathic effects (CPEs) in vitro in a time-dependent manner. Collectively, these findings establish chicken IFN-υ as a functional type IV IFN with conserved structural features, regulated expression, defined receptor usage, and potent antiviral activity, providing new insights into avian IFN system and highlighting its potential relevance for antiviral immunity in poultry.Keywords: Type IV IFN, IFN-υ, Receptor, Gallus gallus, Antiviral activity Introduction Interferons (IFNs), a family of helical cytokines, function as pivotal regulators of host immunity, particularly in antiviral defense and immune modulation (Ouyang et al., 2011; Pestka, 2007). IFNs can be systematically grouped into four distinct categories according to their molecular architecture, chromosomal organization, receptor complexes, and intracellular signaling mechanisms, that is type I, type II, type III, and the recently recognized type IV IFNs (Chen et al., 2022a; Isaacs and Lindenmann, 1957; Kotenko et al., 2003; Naylor et al., 1983). Since the seminal observation of IFN activity in late 1950s, continuous identification of novel IFN lineages has greatly expanded the knowledge on the evolutionary diversification and functional complexity of IFN-mediated immune responses (Chen et al., 2022a; Isaacs and Lindenmann, 1957; Kotenko et al., 2003; Pestka, 2007). Type I IFNs are the most extensively studied IFN family and are widely distributed across vertebrates, comprising multiple subtypes with conserved antiviral functions (Chen et al., 2022c; Gan et al., 2020; Krause and Pestka, 2005). Despite lineage-specific gene expansion and receptor duplication, particularly in teleost fish, they signal through homologous interferon-α/β receptor (IFNAR) complexes to activate the Janus kinase–signal transducer and activator of transcription (JAK–STAT) pathway, leading to IFN-stimulated gene factor 3 (ISGF3) formation and induction of IFN-stimulated genes (ISGs) (Negishi et al., 2018; Stark and Darnell, 2012). Type II IFN, i.e. IFN-γ is typically encoded by a single gene (except in fish) and signals via IFN-γ receptor (IFNGR) complexes to induce signal transducer and activator of transcription 1 (STAT1) homodimers, primarily mediating immunoregulatory and inflammatory responses (Gan et al., 2020; Schroder et al., 2004). Type III IFNs, or IFN-λs, signal through a receptor complex of IFN-λ receptor 1 (IFN-λR1) and interleukin-10 receptor beta (IL-10RB); although they share downstream pathways with type I IFNs, their activity is largely restricted to epithelial and mucosal tissues (Kotenko et al., 2003; Mendoza et al., 2017). The recently identified type IV IFN, IFN-υ, represents a phylogenetically distinct IFN lineage, which is conserved across a broad range of vertebrates, including fish, amphibians, reptiles, birds, and early mammals (Chen et al., 2022b, 2023a, b; Pang et al., 2024). IFN-υ shows low sequence similarity to other class II cytokines and forms an independent clade within the IFN family, indicating a unique evolutionary origin. It signals through a heterodimeric receptor complex consisting of IFN-υR1 and IL-10RB, a shared subunit also used by type III IFNs (Chen et al., 2022b; Kotenko et al., 2003; Li et al., 2024; Pang et al., 2024). Functional studies in teleosts and amphibians demonstrate that IFN-υ and its receptors are constitutively expressed and inducible by poly(I:C) or viral infection, activating the JAK–STAT pathway to induce ISGs and confer antiviral activity (Chen et al., 2022a, 2023b; Liu et al., 2024) In avian species, however, the type IV IFN system remains poorly characterized. To date, functional evidence has been reported only in duck, where IFN-υ, IFN-υR1, and IL-10RB were shown to be inducible by innate immune stimuli and capable of activating ISG expression and antiviral responses (Pang et al., 2024). Whether a similar IFN-υ signaling axis exists in chicken (Gallus gallus), and how it compares with that of duck and other vertebrates in terms of expression pattern, receptor usage, and antiviral activity, remains largely unknown. In this study, we identified and characterized IFN-υ and its receptor subunits IFN-υR1 and IL-10RB in chicken, analyzed their basal and poly(I:C)-induced expression patterns, evaluated the biological activity of recombinant chicken IFN-υ in inducing representative ISGs and verified ligand–receptor interaction using chimeric receptor systems. Furthermore, we employed Tembusu virus (TMUV), a mosquito-borne flavivirus infecting a wide range of avian hosts such as duck and chicken (Huang et al., 2025; Zhang et al., 2017), in the present study to examine the antiviral effect of recombinant IFN-υ in restricting TMUV replication. Collectively, these findings provide new insights into type IV IFN signaling in avian innate immunity and advance our understanding of IFN system diversification during vertebrate evolution. Materials and methods Animals, virus, cells, and reagents One-day-old chickens were obtained from a commercial hatchery in Shandong Province, China, and maintained in isolators on standard commercial feed for seven days. All procedures were in accordance with the Institutional Animal Care and Use Committee of Qingdao Agricultural University with approval number 2026011501. DF-1 chicken embryo fibroblast cells were maintained in our laboratory and cultured in Dulbecco’s modified Eagle’s medium (DMEM; Corning, Manassas, VA) supplemented with 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA) at 37°C in a humidified incubator containing 5% CO₂. Chicken embryo fibroblast (CEF) cells were prepared from 10-day-old chicken embryos as described previously (Pang et al., 2024, 2025). Briefly, embryos were aseptically collected, tissues were minced and digested with 0.25% trypsin, and the resulting cell suspensions were cultured in DMEM supplemented with 10% FBS. TMUV maintained in our laboratory was used for viral infection assays. The synthetic double-stranded RNA analogue polyinosinic–polycytidylic acid (poly(I:C); Sigma-Aldrich, P1530) was used for immune stimulation experiments. RNA extraction, cDNA synthesis and quantitative real-time PCR Total RNA was extracted from tissues or cultured cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. RNA concentration and purity were determined using a NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) by measuring absorbance at 260 nm and the A260/A280 ratio. First-strand complementary DNA (cDNA) was synthesized from 1 μg total RNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, K1622), following the manufacturer’s instruction. Quantitative real-time PCR (qRT-PCR) was performed to analyze the tissue distribution of IFN-υ and its putative receptor genes, as well as their expression changes in tissue samples, including heart, liver, lung, spleen, thymus, bursa of Fabricius, intestine, kidney, brain and muscle following intraperitoneal poly(I:C) administration. To assess ISG response, DF-1 cells were incubated with recombinant IFN-υ protein, and the relative expression levels of representative ISGs, including IFI6, RSAD2, IRF1, and MX1, were quantified by qRT-PCR. For viral replication analysis, TMUV RNA levels in infected CEF cells were determined by qRT-PCR targeting the nonstructural protein 5 (NS5) gene. Gene-specific primers for IFN-υ, its candidate receptors IFN-υR1 and IL-10RB, and IFI6, RSAD2, IRF1, MX1, TMUV NS5 are listed in Table 1 with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as reference gene. Amplification was performed on a QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific) using SYBR Green chemistry. Each 20 μL reaction contained 10 μL SYBR Master Mix (Applied Biosystems), 1 μL diluted cDNA template, 0.2 μM of each primer, and nuclease-free water. The thermal cycling conditions were as the followings: initial denaturation at 95°C for 3 min, followed by 42 cycles of 95°C for 10 s, 60°C for 20 s, and 72°C for 20 s. Relative gene expression levels were calculated using the 2–ΔΔCT method, normalized to GAPDH, and expressed as fold changes relative to the corresponding control groups. Data were presented as mean ± standard deviation (SD) from three independent experiments. Table 1PCR primers used in this study.Table 1 dummy alt textPrimerSequence 5′−3′UsagepET-22b-IFN-υ-FAATCGACAAAGCAACATCCAGAAAATGTGCCAGTCCCGGAProtein expressionpET-22b-IFN-υ-RTTAATGTGTTGATCTTCTCCGGGTTCTGTCTCATTGCTGGIFN-υ-FCATGATCACGCAGCCATTGTReal-time PCRIFN-υ-RGTCTTGAGTTGGGCATGAGCIL-10RB-FTACGGCTCGTGGATTTACCGIL-10RB-RATATCGTCCACGGCTCCAACIFN-υR1-FCGCCTGTACCGTGAGAATGTIFN-υR1-RTTGTGGCTCTATGCCCACTGGAPDH-FGGCACTGTCAAGGCTGAGAAGAPDH-RTGCATCTGCCCATTTGATGTIRF1-FCGTTGAGGGGAAAGGCTTCTIRF1-RGGAACTCCAACTCTGCCGAAIFI6-FGTCCACAAAGCCGGTTTCACIFI6-RAGCCTTTGGCACCCATTTCTMX1-FACGGTCCAACTTCAGCTCAGMX1-RGATTGCTGCAGCCTAATGGCRSAD2-FCAGGGAACGGTGGTTCAAGARSAD2-RCCTTCCTTGACCACGACCAATMUV-NS5-FACAGGCTCAGCCAGCTCAATTMUV-NS5-RGCTGTTGCCCAAAAGGAGTG PCR primers used in this study. Bioinformatics analysis The Gallus gallus genome (GenBank accession: GCA_016699485.1) was searched for type IV IFN and its putative receptor genes using homologous sequences from other vertebrates. Protein sequences were deduced from nucleotide sequences using the ExPASy translation tool. Sequence similarity searches were performed using BLAST. Transmembrane domains and signal peptides were predicted using TMHMM Server v2.0 and SignalP 4.1, respectively. Multiple sequence alignments were generated using the ClustalW algorithm in BioEdit, and phylogenetic trees were constructed using the neighbor-joining method in MEGA 6.0 with 1,000 bootstrap replicates. Primers for qRT-PCR were designed using Primer3 (Table 1). Expression analysis of IFN-υ, IFN-υR1 and IL-10RB in chicken To assess basal gene expression, tissues including heart, liver, lung, spleen, thymus, bursa of Fabricius, small intestine, kidney, brain, and skeletal muscle were collected from four healthy chickens. Total RNA was extracted using TRIzol reagent (Invitrogen). To examine expression following stimulation, 15 healthy animals were intraperitoneally injected with poly(I:C) (10 mg/kg body weight) and divided into five groups (n = 3 per group). A control group (n = 3) received sterile phosphate-buffered saline (PBS, pH 7.2–7.4). At 0, 4, 8, 12, and 24 h post-injection, animals were euthanized, and liver, spleen, bursa of Fabricius and kidney tissues were collected for RNA extraction using TRIzol. Animals were humanely euthanized by bloodletting before sampling. Production and purification of recombinant IFN-υ protein To obtain the open reading frames (ORFs) of IFN-υ gene-specific primers were designed according to predicted ORF sequences (Table 1). Target ORFs were amplified by PCR using mixed-tissue cDNA as the template. The plasmid pET-22b-IFN-υ was transformed into Escherichia coli Rosetta (DE3) competent cells. Bacterial cultures were induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 37°C for 6 h with shaking at 180 rpm. Cells from 5 L cultures were harvested by centrifugation at 4,000 × g for 30 min at 4°C, resuspended in 100 mL PBS, and disrupted by high-pressure homogenization (800 bar). Cell lysates were centrifuged at 8,000 × g for 10 min at 4°C to isolate inclusion bodies, which were washed twice with washing buffer 1 (50 mM Tris-HCl, 300 mM NaCl, 10 mM EDTA, 0.5% Triton X-100, and 0.1% dithiothreitol (DTT), pH 8.0) and once with washing buffer 2 (50 mM Tris-HCl, 100 mM NaCl, 10 mM EDTA, and 0.1% DTT, pH 8.0). The inclusion bodies were dissolved in denaturing buffer containing 6 M guanidine hydrochloride, 10% glycerol, 50 mM Tris-HCl, 100 mM NaCl, and 10 mM EDTA to a final protein concentration of 30 mg/mL. For protein refolding, 10 mL of denatured protein solution was slowly added to 1 L refolding buffer (100 mM Tris-HCl, 2 mM EDTA, 400 mM L-arginine-HCl, 0.5 mM oxidized glutathione, and 5 mM reduced glutathione, pH 8.0) with gentle stirring at 4°C for 48 h. The refolded protein was concentrated to 30 mL using a 10 kDa molecular weight cut off ultrafiltration device, mixed with 120 mL equilibration buffer (20 mM Tris-HCl, pH 8.0, 300 mM NaCl), and clarified by centrifugation at 10,000 × g for 10 min at 4°C. The protein solution was further concentrated and purified by size-exclusion chromatography using a Superdex 75 column (GE Healthcare). To assess the aggregation state of recombinant IFN-υ in solution, gel filtration calibration was performed using standard molecular weight markers of 29 kDa and 3.7 kDa, which were run under identical chromatographic conditions. The elution profile of IFN-υ was compared with standards to estimate its apparent molecular mass and oligomeric state. Protein purity was analyzed by SDS–PAGE, protein concentration was determined using a bicinchoninic acid (BCA) assay, and purified IFN-υ was stored at −80°C until use. Induction of immune-related genes by recombinant IFN-υ DF-1 cells were seeded in 12-well plates and cultured to approximately 80% confluence. Cells were washed once with PBS and then incubated with recombinant IFN-υ at a final concentration of 2 μg/mL for 2, 12, or 24 h. Control cells were treated with an equal volume of PBS for the corresponding time points. Following IFN-υ stimulation, cells were harvested for downstream gene expression analysis of IFI6, RSAD2, IRF1, and MX1 as described above. Antiviral assay of IFN-υ against TMUV To evaluate the antiviral activity of chicken IFN-υ, CEF cells were seeded into 24-well plates and cultured until approximately 80% confluence. Cells were pretreated with recombinant IFN-υ protein at a final concentration of 2 μg/mL for 12 h, while PBS treatment served as negative control. Following pretreatment, cells were infected with TMUV at dilution ratios of 1:10, 1:20, or 1:40. After virus adsorption for 1 h at 37°C, the inoculum was removed and replaced with fresh maintenance medium containing 2% FBS. Cells were incubated for 60 h post-infection (hpi), and virus-induced cytopathic effects were assessed by crystal violet staining. Briefly, cells were fixed with 4% paraformaldehyde for 20 min, washed with PBS, stained with 0.1% crystal violet for 15 min, rinsed thoroughly with distilled water, and air-dried prior to imaging. For quantitative evaluation of viral replication, CEF cells pretreated with IFN-υ or PBS were infected with TMUV at a dilution ratio of 1:20 and harvested at 24, 36, and 48 hpi for RNA extraction and NS5 gene quantification by qRT-PCR, as described above. Statistical analysis Data are presented as mean ± standard deviation (SD) from at least three independent experiments. Statistical analyses were performed using SPSS 22.0, and graphs were generated with GraphPad Prism 5.0. Differences were considered statistically significant at P < 0.05. Significant values are indicated as P < 0.05 (*), P < 0.01 (**) and P < 0.001 (***). Results Sequence characteristics of IFN-υ in chicken The chicken IFN-υ gene is 528 nucleotides long, and encodes a putative protein of 175 amino acids (aa) (GenBank accession no: PP465981.1). Conserved domain analysis revealed that the IFN-υ protein contained an N-terminus signal peptide, being in residues 1-20 aa. Synteny analysis demonstrated that the genomic organization of the IFN-υ locus is strongly conserved across vertebrates. In chicken, IFN-υ is located between ADARB2 and PFKP, forming a collinear block that mirrors the corresponding regions in human, zebrafish, and anole, suggesting an evolutionarily conserved gene arrangement (Fig. 1A). Multiple sequence alignment of IFN-υ proteins from representative vertebrate lineages revealed extensive conservation, particularly within the predicted α-helical regions, the C-terminal CAWE motif and conserved sequence CXXXXX[W/L] which is invariant among all examined species (Fig. 1B). The alignment also highlighted preserved cysteine residues and a canonical six-helix bundle architecture characteristic of class II cytokines. These findings collectively indicate strong evolutionary constraint on IFN-υ and underscore key structural elements which may underpin its receptor interaction and biological activity. Genomic conservation and structural features of IFN-υ proteins from chicken and representative vertebrates. (A) Synteny analysis of the IFN-υ locus in human, zebrafish, anole, and chicken. The arrows represent the direction of gene transcription. The following genome sequences were searched for the information: human genome assembly no. GRCh38.p14, zebrafish: no. GRCz11, anole: no. rAnoCar3.1. pri, chicken: no. GRCh38.p14. (B) Multiple sequence alignment of IFN-υ proteins from chicken and representative vertebrates. The putative signal peptide, predicted α-helices (αA–αF), conserved cysteine residues, conserved sequence CXXXXX[W/L], and fully conserved C-terminal CAWE motif are indicated. Highly conserved amino acids are highlighted in red. To clarify the evolutionary position of chicken IFN-υ, a Neighbor-Joining phylogenetic tree was generated using vertebrate IFN sequences with 1000 bootstrap replicates (Fig. 2). Four well-defined IFN classes were resolved, with chicken IFN-υ was clustered with avian IFN-υ members in the type IV IFN lineage, being clearly separated from classical type I, II, and III IFNs. This placement supports chicken IFN-υ as part of an ancient and distinct IFN family conserved across vertebrates. Phylogenetic analysis of IFN-υ in chicken and other vertebrates. Predicted amino-acid sequences were used to construct the phylogenetic tree by the neighbor-joining (NJ) method in MEGA X with 1000 bootstrap replicates. Four IFN classes (Type I–IV) are shown with shaded backgrounds, and the newly analyzed chicken IFN-υ is indicated with a black star. The GenBank accession numbers of all IFN genes included in the analysis are listed in supplementary Table 1. Constitutive and poly(I:C)-induced expression of IFN-υ in chicken The tissue distribution of chicken IFN-υ was examined by quantitative real-time PCR in healthy individuals. IFN-υ transcripts were detectable in all examined tissues, although the expression levels varied considerably among organs. Relatively low expression was observed in liver, kidney and muscle, whereas higher basal expression levels were detected in immune-related tissues, including spleen, bursa of Fabricius and thymus. Notably, the highest expression level was observed in thymus, followed by lung and intestine, suggesting a potential role of IFN-υ in immune surveillance at both systemic and mucosal sites (Fig. 3A). Tissue distribution and poly(I:C)-induced expression of chicken IFN-υ. (A) Basal expression levels of IFN-υ mRNA in various tissues of healthy chickens were determined by quantitative real-time PCR. Data are presented as relative expression normalized to the internal reference gene. (B) Temporal expression patterns of IFN-υ in liver, bursa of Fabricius, kidney and spleen following poly(I:C) stimulation at the indicated time points (4 h, 8 h, 12 h and 24 h). Expression levels are shown as fold change relative to the corresponding untreated control. Data represent mean ± SD. Asterisks indicate statistically significant differences compared with the control group (* P < 0.05; ** P < 0.01). To assess the inducibility of IFN-υ during innate immune stimulation, chickens were challenged with poly(I:C), and IFN-υ expression was analyzed in selected immune-related tissues at different time points. In liver, IFN-υ expression was significantly upregulated at 4 h and increased further at 8 h and 12 h post-stimulation, reaching a peak level before declining at 24 h. In the bursa of Fabricius, a moderate but significant induction of IFN-υ was observed at 8 h and 12 hpi. In contrast, IFN-υ expression in kidney showed a delayed response, with a significant increase detected at 24 h, whereas splenic expression exhibited a transient induction at later time points. These results indicate that chicken IFN-υ is differentially regulated across tissues in response to poly(I:C) stimulation, displaying both tissue-specific and time-dependent expression patterns (Fig. 3B). Induction of IFN-stimulated genes by IFN-υ Recombinant chicken IFN-υ was successfully expressed in E. coli and purified to homogeneity, as indicated by SDS-PAGE with a single major band at the expected molecular mass. Size-exclusion chromatography further revealed that the elution peak of IFN-υ appeared between 13.7 kDa and 29 kDa standard protein markers. Considering the predicted molecular weight of chicken IFN-υ (18.5 kDa), the size-exclusion chromatography elution behavior supported that IFN-υ exists predominantly as a monomer in aqueous solution (Fig. 4A). To assess its biological activity, DF-1 cells were stimulated with the purified IFN-υ protein, and the expression of representative (ISGs was examined. IFN-υ treatment induced the upregulation of IFI6, RSAD2, IRF1, and MX1, with IRF1 and MX1 showing significant increase at specific time points (Fig. 4B). These data collectively demonstrate that recombinant chicken IFN-υ is properly folded, monomeric in solution, and capable of activating downstream antiviral gene expression. Expression, purification, and functional activity of recombinant chicken IFN-υ. (A) SDS-PAGE analysis (inset) showing purified recombinant chicken IFN-υ as a single major band at the expected molecular size. Size-exclusion chromatography (SEC) profiles comparing IFN-υ (blue line) with standard proteins of 13.7 kDa (black dashed line) and 29 kDa (red dotted and dashed line). The elution peak of IFN-υ appears between the two molecular mass markers, and together with the predicted molecular weight of chicken IFN-υ, indicating that the protein predominantly exists as a monomer in aqueous solution. (B) Relative expression levels of IFN-stimulated genes (IFI6, RSAD2, IRF1, MX1) in chicken cells stimulated with recombinant IFN-υ for 2 h, 12 h, and 24 h. Data represented fold changes relative to untreated controls were expressed as mean ± SD. asterisks (*) denote significant up-regulation (P < 0.05). Antiviral activity of IFN-υ against TMUV To further evaluate the antiviral activity of IFN-υ against TMUV, virus-induced cytopathic effects (CPEs) and viral replication levels were examined in IFN-υ–treated and control cells. As shown in Fig. 5A, pronounced CPEs characterized by extensive cell death and monolayer disruption was observed in control cells infected with TMUV. Serial dilution of viral supernatants resulted in a gradual reduction of CPE intensity; however, evident cytopathic damage was still detectable in the control group. In contrast, IFN-υ–treated cells exhibited markedly reduced CPEs across all tested dilutions, indicating that IFN-υ treatment effectively protects cells from TMUV-induced cytopathology. Detection of activity of chicken IFN-υ. (A) Cytopathic effects (CPE) induced by TMUV infection in control and IFN-υ–treated cells. Viral supernatants were serially diluted as indicated, and CPE was visualized by crystal violet staining. (B) Relative mRNA expression levels of TMUV were quantified by qRT-PCR at 0, 24, 36, and 48 hpi in control and IFN-υ–treated cells. TMUV expression was normalized to the internal reference gene and expressed relative to the 0 h control group. Data are presented as mean ± SD from three independent experiments. Statistical significance was determined by Student’s t-test. *** P < 0.001. Consistent with these observations, qRT-PCR analysis revealed that IFN-υ significantly suppressed TMUV replication (Fig. 5B). At 24 and 36 hpi, viral mRNA expression increased substantially in control group, whereas IFN-υ treatment resulted in a pronounced reduction of viral RNA levels. At 48 hpi, viral replication reached its highest level in control cells, while viral mRNA expression level in IFN-υ–treated cells remained significantly lower. Together, these results demonstrate that IFN-υ effectively inhibits TMUV replication and attenuates virus-induced CPEs in a time-dependent manner. Constitutive and poly(I:C)-Induced expression of IFN-υR1 and IL-10RB in chicken Basal expression of IL-10RB and IFN-υR1 was detected in all examined chicken tissues, although expression levels varied markedly among organs. IL-10RB showed relatively low basal expression in muscle, heart, brain and liver, whereas higher expression was observed in immune-related and mucosal tissues, including bursa of Fabricius, intestine, lung and spleen, with the highest level detected in spleen (Fig. 6A). Similarly, IFN-υR1 was broadly expressed, with minimal expression levels in muscle, liver and brain, and intermediate levels in thymus and kidney, and relatively higher expression levels in spleen, bursa of Fabricius, lung and intestine (Fig. 6C). Constitutive and poly(I:C)-induced expression of IL-10RB and IFN-υR1 in chicken. (A) Basal expression levels of IL-10RB mRNA in various tissues of healthy chickens. (B) Temporal expression patterns of IL-10RB in kidney, liver, spleen and thymus following poly(I:C) stimulation at 4 h, 8 h, 12 h and 24 h. (C) Basal expression levels of IFN-υR1 mRNA in various tissues of healthy chickens. (D) Temporal expression patterns of IFN-υR1 in spleen, thymus, kidney and bursa of Fabricius following poly(I:C) stimulation. Gene expression was determined by quantitative real-time PCR and normalized to an internal reference gene. Data are presented as fold change relative to the corresponding untreated control and expressed as mean ± SD. Asterisks indicate statistically significant differences compared with the control group (* P < 0.05; ** P < 0.01). Following poly(I:C) stimulation, IL-10RB expression exhibited tissue- and time-dependent regulation. In liver, IL-10RB was significantly upregulated at 8 h and 12 h post-stimulation, followed by reduction at 24 h. In thymus, a marked induction was observed at 8 h, whereas changes in kidney and spleen were moderate or transient across the examined time points (Fig. 6B). In contrast, poly(I:C)-induced expression of IFN-υR1 displayed distinct kinetics. Significant upregulation of IFN-υR1 was detected in spleen and thymus at early time points, particularly at 8 h and 12 h post-stimulation. In kidney, IFN-υR1 expression increased significantly at 24 h, whereas expression in the bursa of Fabricius remained relatively stable throughout the stimulation period (Fig. 6D). Together, these data demonstrate that IL-10RB and IFN-υR1 are constitutively expressed in chicken tissues and are differentially responsive to poly(I:C) challenge. Discussion In this study, chicken IFN-υ was found to exhibit conserved features in genomic organization, structural feature, receptor usage, and to have robust antiviral activity. Functionally, IFN-υ induced a panel of classical ISGs and effectively suppressed TMUV replication in vitro, thereby providing comprehensive evidence that avian type IV IFN represents a functional and biologically active IFN system. Type IV IFN is capable of inducing ISG expression and inhibiting viral replication in teleost fish, amphibian, and duck, with early studies demonstrating its role in inducing canonical ISGs including IRF1, Mx and Viperin to exert antiviral functions, and subsequent studies confirming these conserved activities in multiple fish species (Chen et al., 2022b, 2023a, 2023b; Pang et al., 2024; Dai et al., 2025; Li et al., 2024; Liu et al., 2024). Transcriptomic studies have further revealed that IFN-υ triggers 165 ISGs in blunt snout bream and 400 ISGs in Xenopus laevis, among which 268 genes are unique and not annotated in human or zebrafish ISG datasets (Chen et al., 2023b; Li et al., 2024). Building on these studies, our results in chicken further confirm that the ability of type IV IFN in inducing ISGs and in restricting viral replication is conserved across vertebrate lineages. Notably, chicken IFN-υ displayed robust antiviral activity against TMUV and effectively induced representative ISGs, suggesting that it plays a similar role in avian innate immunity. However, whether chicken IFN-υ also regulates a broad and potentially unique repertoire of ISGs, as observed in fish and amphibians, remains to be determined and warrants further transcriptomic analysis. From an evolutionary perspective, our findings further support the concept that type IV IFN constitutes an ancient and conserved IFN lineage across vertebrates. Comparative synteny and phylogenetic analyses revealed that chicken IFN-υ is embedded within a highly conserved genomic locus and clusters distinctly within the type IV IFN clade, consistent with observations in teleost fish, amphibians, and ducks (Chen et al., 2022b, 2023b; Pang et al., 2024). Together with recent functional studies in grass carp demonstrating anti-infective roles of type IV IFN in vivo (Liu et al., 2024), these data suggest that type IV IFN emerged early during vertebrate evolution and has been selectively retained to fulfill conserved antiviral functions. At the molecular level, the type IV IFN shares hallmark structural features with other class II cytokines, including the predicted six-helix bundle architecture and conserved cysteine residues, yet remains clearly distinct from type I and type III IFNs. IFN-υ signals through a heterodimeric receptor complex composed of IFN-υR1 and the shared subunit IL-10RB, which is also utilized by type III IFNs and other IL-10 family cytokines (Kotenko et al., 2003; Ouyang et al., 2011). This shared receptor usage raises important questions regarding signaling specificity and pathway crosstalk. Previous structural and biochemical studies have shown that subtle differences in ligand–receptor binding geometry and receptor assembly can profoundly influence downstream signaling amplitude and duration (Chen et al., 2022a; Lazear et al., 2019). Thus, the type IV IFN may activate a partially overlapping yet distinct transcriptional program compared with I IFNs and III IFNs, contributing to functional diversification within the IFN system. The antiviral activity of type IV IFN against TMUV observed in this study is of particular biological relevance. TMUV is a pathogenic flavivirus that poses a serious threat to poultry health and has been widely used as a model to study avian innate immune responses (Li et al., 2020; Zhang et al., 2017). Previous work has demonstrated that type I and type III IFNs restrict TMUV replication both in vitro and in vivo, albeit with differences in tissue specificity and antiviral potency (Zhou et al., 2023). Our results revealed that type IV IFN also efficiently suppresses TMUV replication, supporting the notion that multiple IFN systems cooperate to shape antiviral immunity in avian species. Given that type IV IFN receptors are broadly expressed, type IV IFN may contribute to antiviral defense at both systemic and mucosal sites, complementing the actions of I IFNs and III IFNs. Despite these advances, several questions remain to be addressed. First, the in vivo contribution of type IV IFN during natural viral infection in birds remains unclear. Second, the extent to which type IV IFN signaling overlaps or synergizes with type I IFNs and type III IFNs pathways requires further investigation, particularly at the level of IFN regulatory factors (IRFs) and downstream signaling kinetics (Wang et al., 2024). Finally, whether type IV IFN preferentially regulates a distinct subset of ISGs or modulates antiviral responses with reduced inflammatory cost remains an intriguing possibility. Addressing these questions will be essential for fully understanding the role of type IV IFN in avian immunity and the evolutionary diversification of vertebrate IFN systems (Pestka, 2007; Su, 2022). Disclosures The authors have no conflicts of interest to declare. Author contribution Shan Zhang: Conceptualization, Data analysis, Investigation. Tian Shun Wei: Investigation. Chao Wei Zhang: Investigation. Xiao Yuan Xu: Investigation. Jing Wei Song: Investigation. Peng Fei Mu: Data analysis. Bang Xiao: Data analysis. Su Wang: Data analysis. Bo Li: Data analysis. Pin Nie: Supervision. Acknowledgements This work was supported by Shandong Provincial Natural Science Foundation (ZR2023QD181). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.psj.2026.107229. Supplementary materials References Associated Data Supplementary Materials